Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 14.03
(10.04%)
CNY 14.03
(10.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.47 Billion CNY | -233.14% |
| 2022 | -743.98 Million CNY | -78.74% |
| 2021 | -416.22 Million CNY | -167.83% |
| 2020 | 613.64 Million CNY | 100.09% |
| 2019 | 306.69 Million CNY | 225.64% |
| 2018 | -244.11 Million CNY | 34.74% |
| 2017 | -374.05 Million CNY | -52.24% |
| 2016 | -245.69 Million CNY | -731.86% |
| 2015 | 38.88 Million CNY | 141.7% |
| 2014 | -93.25 Million CNY | -130.06% |
| 2013 | 310.21 Million CNY | 0.46% |
| 2012 | 308.8 Million CNY | 13.5% |
| 2011 | 272.07 Million CNY | 50.57% |
| 2010 | 180.69 Million CNY | 64.33% |
| 2009 | 109.95 Million CNY | -28.4% |
| 2008 | 153.56 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -2.12 Billion CNY | 14.43% |
| 2024 Q2 | -2.22 Billion CNY | -5.03% |
| 2024 Q3 | -2.29 Billion CNY | -2.44% |
| 2023 Q2 | -3.12 Billion CNY | 3.86% |
| 2023 FY | -2.47 Billion CNY | -233.14% |
| 2023 Q1 | -3.25 Billion CNY | -337.58% |
| 2023 Q3 | -2.91 Billion CNY | 6.89% |
| 2023 Q4 | -2.47 Billion CNY | 14.95% |
| 2022 FY | -743.98 Million CNY | -78.74% |
| 2022 Q4 | -743.98 Million CNY | 27.85% |
| 2022 Q3 | -1.03 Billion CNY | -24.06% |
| 2022 Q2 | -831.2 Million CNY | -16.84% |
| 2022 Q1 | -711.38 Million CNY | -70.91% |
| 2021 Q1 | -249.73 Million CNY | -140.7% |
| 2021 Q4 | -416.22 Million CNY | -44.03% |
| 2021 Q2 | -374.03 Million CNY | -49.78% |
| 2021 Q3 | -288.98 Million CNY | 22.74% |
| 2021 FY | -416.22 Million CNY | -167.83% |
| 2020 Q2 | 422.48 Million CNY | 344.58% |
| 2020 FY | 613.64 Million CNY | 100.09% |
| 2020 Q3 | 424.55 Million CNY | 0.49% |
| 2020 Q4 | 613.64 Million CNY | 44.54% |
| 2020 Q1 | 95.02 Million CNY | -69.01% |
| 2019 FY | 306.69 Million CNY | 225.64% |
| 2019 Q2 | -149.72 Million CNY | 48.95% |
| 2019 Q3 | -233.21 Million CNY | -55.76% |
| 2019 Q1 | -293.27 Million CNY | -20.14% |
| 2019 Q4 | 306.69 Million CNY | 231.51% |
| 2018 Q1 | -330.88 Million CNY | 11.54% |
| 2018 FY | -244.11 Million CNY | 34.74% |
| 2018 Q4 | -244.11 Million CNY | 2.89% |
| 2018 Q3 | -251.36 Million CNY | 20.24% |
| 2018 Q2 | -315.16 Million CNY | 4.75% |
| 2017 Q3 | -369.51 Million CNY | -24.06% |
| 2017 Q4 | -374.05 Million CNY | -1.23% |
| 2017 FY | -374.05 Million CNY | -52.24% |
| 2017 Q1 | -277.23 Million CNY | -12.84% |
| 2017 Q2 | -297.84 Million CNY | -7.43% |
| 2016 Q1 | 149.46 Million CNY | 284.38% |
| 2016 Q4 | -245.69 Million CNY | -2.64% |
| 2016 Q3 | -239.36 Million CNY | -60.9% |
| 2016 Q2 | -148.77 Million CNY | -199.54% |
| 2016 FY | -245.69 Million CNY | -731.86% |
| 2015 Q4 | 38.88 Million CNY | -84.4% |
| 2015 Q3 | 249.33 Million CNY | 30.43% |
| 2015 Q2 | 191.16 Million CNY | 281.36% |
| 2015 Q1 | -105.4 Million CNY | -13.02% |
| 2015 FY | 38.88 Million CNY | 141.7% |
| 2014 Q1 | 132.31 Million CNY | -57.35% |
| 2014 Q4 | -93.25 Million CNY | 73.89% |
| 2014 Q2 | 402.15 Million CNY | 203.94% |
| 2014 Q3 | -357.12 Million CNY | -188.8% |
| 2014 FY | -93.25 Million CNY | -130.06% |
| 2013 Q4 | 310.21 Million CNY | 0.0% |
| 2013 FY | 310.21 Million CNY | 0.46% |
| 2012 FY | 308.8 Million CNY | 13.5% |
| 2011 FY | 272.07 Million CNY | 50.57% |
| 2010 FY | 180.69 Million CNY | 64.33% |
| 2009 FY | 109.95 Million CNY | -28.4% |
| 2008 FY | 153.56 Million CNY | 0.0% |